Cargando…
The interaction of ifosfamide and aprepitant in gynecologic malignancies()
• Aprepitant combined with ifosfamide may lead to encephalopathy. • Aprepitant–ifosfamide induced encephalopathy was of short duration in these cases.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862235/ https://www.ncbi.nlm.nih.gov/pubmed/24371715 http://dx.doi.org/10.1016/j.gynor.2013.06.002 |
| _version_ | 1782295724412633088 |
|---|---|
| author | Shindorf, Mackenzie L. Manahan, Kelly J. Geisler, John P. |
| author_facet | Shindorf, Mackenzie L. Manahan, Kelly J. Geisler, John P. |
| author_sort | Shindorf, Mackenzie L. |
| collection | PubMed |
| description | • Aprepitant combined with ifosfamide may lead to encephalopathy. • Aprepitant–ifosfamide induced encephalopathy was of short duration in these cases. |
| format | Online Article Text |
| id | pubmed-3862235 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38622352013-12-26 The interaction of ifosfamide and aprepitant in gynecologic malignancies() Shindorf, Mackenzie L. Manahan, Kelly J. Geisler, John P. Gynecol Oncol Case Rep Case Report • Aprepitant combined with ifosfamide may lead to encephalopathy. • Aprepitant–ifosfamide induced encephalopathy was of short duration in these cases. Elsevier 2013-06-12 /pmc/articles/PMC3862235/ /pubmed/24371715 http://dx.doi.org/10.1016/j.gynor.2013.06.002 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Case Report Shindorf, Mackenzie L. Manahan, Kelly J. Geisler, John P. The interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| title | The interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| title_full | The interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| title_fullStr | The interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| title_full_unstemmed | The interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| title_short | The interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| title_sort | interaction of ifosfamide and aprepitant in gynecologic malignancies() |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862235/ https://www.ncbi.nlm.nih.gov/pubmed/24371715 http://dx.doi.org/10.1016/j.gynor.2013.06.002 |
| work_keys_str_mv | AT shindorfmackenziel theinteractionofifosfamideandaprepitantingynecologicmalignancies AT manahankellyj theinteractionofifosfamideandaprepitantingynecologicmalignancies AT geislerjohnp theinteractionofifosfamideandaprepitantingynecologicmalignancies AT shindorfmackenziel interactionofifosfamideandaprepitantingynecologicmalignancies AT manahankellyj interactionofifosfamideandaprepitantingynecologicmalignancies AT geislerjohnp interactionofifosfamideandaprepitantingynecologicmalignancies |